With positive results, Sarepta may have second gene therapy with potential

With positive results, Sarepta may have second gene therapy with potential

STAT Plus: With positive early results, Sarepta appears to have a second gene therapy with potential

By ADAM FEUERSTEIN

RUBY WALLAU FOR STAT

Sarepta Therapeutics announced early but encouraging results from its second gene therapy program targeting a rare, muscle-wasting disease.

READ MORE